智通财经APP获悉，周二，Hims & Hers Health(HIMS.US)股价走低，截至发稿，该股跌超20%，报41.05美元。该公司四季度毛利率低于预期。该公司报告的毛利率为77%，而StreetAccount调查的分析师预期为78.4%。公司第四季度的每股收益为11美分，高于市场预期的10美分；收入达到4.81亿美元，也超过了市场预期的4.7亿美元。相比去年同期2.466亿美元，该公司本季度的收入增长了95%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.